Sulzer Chairman Ueli Roost resigns
Ueli Roost has announced his resignation with immediate effect as Board Chairman of not only Sulzer Ltd – as previously announced – but also of Sulzer Medica Ltd. Roost thereby intends to afford both companies the greatest possible freedom of action in their current phase of transitional realignment.
Both Boards of Directors respect Ueli Roost’s decision, and express their full appreciation for his services. Leonardo Vannotti has been appointed Chairman of the Sulzer Ltd Board of Directors with immediate effect, and will chair the forthcoming Annual General Meeting on April 19, 2001. Max Link, currently Vice-Chairman of the Sulzer Medica Ltd Board, is today appointed Board Chairman of this publicly listed Sulzer subsidiary.
新苏尔寿公司有限公司董事长莱昂纳多Vannotti comments as follows on current developments: “With the Sulzer Medica spin-off planned for this year, we shall be well on course for a successful future. Both companies have well-founded strategies promising significant value creation. In the interests of our shareholders, we must therefore ensure at the coming Annual General Meeting that InCentive Capital AG does not take control of Sulzer.“
As previously warned by Sulzer, InCentive's AGM resolutions, seeking a replacement of the Sulzer Board by nominees of InCentive, constitute an attempt to take control of Sulzer before the bid is concluded. Sulzer therefore recommends that its shareholders vote against InCentive's resolutions at the AGM. Sulzer rejected the pre-announced bid on 23 February, arguing that the bid is too low and highlighting InCentive's lack of strategy.
